FDA
label_change
· 2018-09-12
FDA Approved: LEVETIRACETAM — Supplemental Application (Prasco Laboratories)
Summary
The FDA granted a supplemental labeling/approval for LEVETIRACETAM through Prasco Laboratories under NDA 207958.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)